| Ms Laura Debora Senderowicz, LCSW | |
|
5999 W State St, Suite B, Boise, ID 83703-3039 | |
| (208) 853-5095 | |
| (208) 853-5125 |
| Full Name | Ms Laura Debora Senderowicz |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 5999 W State St, Boise, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134151707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | LCSW-24830 (Idaho) | Primary |
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
A new study published in Bioscience Hypotheses, a recently launched Elsevier journal, proposes that some people suffering from Alzheimer's disease experience a reduction in their high blood pressure because of cognitive decline.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene,a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that new data from Phase 1 and 2 clinical studies of JX-594 were presented in an oral presentation at the 46th Annual Meeting of the European Association for the Study of the Liver over the weekend at the Internationales Congress Centrum in Berlin, Germany.
New research from the University of Alabama at Birmingham pinpoints the relationship between primary brain tumors and the onset of epileptic seizures and reveals that a drug used to treat Crohn's disease inhibits those seizures and may be able to slow a tumor's growth.
Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Laura Debora Senderowicz, LCSW 7154 W State St, Suite 389, Boise, ID 83714-7421 Ph: (208) 853-5095 | Ms Laura Debora Senderowicz, LCSW 5999 W State St, Suite B, Boise, ID 83703-3039 Ph: (208) 853-5095 |
News Archive
A new study published in Bioscience Hypotheses, a recently launched Elsevier journal, proposes that some people suffering from Alzheimer's disease experience a reduction in their high blood pressure because of cognitive decline.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene,a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that new data from Phase 1 and 2 clinical studies of JX-594 were presented in an oral presentation at the 46th Annual Meeting of the European Association for the Study of the Liver over the weekend at the Internationales Congress Centrum in Berlin, Germany.
New research from the University of Alabama at Birmingham pinpoints the relationship between primary brain tumors and the onset of epileptic seizures and reveals that a drug used to treat Crohn's disease inhibits those seizures and may be able to slow a tumor's growth.
Geron Corporation today announced preclinical study data showing positive effects of GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells (hESCs), in a small animal model of acute heart damage. Administering GRNCM1 by injection into the heart resulted in greater resistance to induced arrhythmias, halted adverse cardiac remodeling and preserved mechanical function compared to controls.
› Verified 5 days ago
Mr. Johnny Josiah Meehan, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6855 W Fairview Ave, Boise, ID 83704 Phone: 208-323-9600 Fax: 208-323-9606 | |
Kristie Kaes, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2121 Fax: 208-367-7305 | |
John Bradford Hunt, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 202 N 9th St Ste 201c, Boise, ID 83702 Phone: 208-549-9597 | |
Dr. Paula K Barrett, PSYD, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 444 W Fort St Fl 2, Boise, ID 83702 Phone: 208-422-1018 | |
Rachel Jessen, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 5985 W State St, Boise, ID 83703 Phone: 208-853-0071 Fax: 208-853-9422 | |
Mr. Tom C Ahlrichs, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-367-6044 Fax: 208-375-8817 | |
Mrs. Amy Niblock Balzer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1720 N Westgate Dr, Suite A-1, Boise, ID 83704 Phone: 208-334-0874 Fax: 208-334-0812 |